ALNYLAM PHARMACEUTICALS INC's ticker is and the CUSIP is 02043Q907. A total of 4 filers reported holding ALNYLAM PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $893,000 | -46.9% | 16,100 | -39.9% | 0.00% | -50.0% |
| Q1 2016 | $1,682,000 | +70.2% | 26,800 | +155.2% | 0.00% | +100.0% |
| Q4 2015 | $988,000 | -77.1% | 10,500 | -80.4% | 0.00% | -75.0% |
| Q3 2015 | $4,307,000 | -44.3% | 53,600 | -16.9% | 0.00% | -42.9% |
| Q2 2015 | $7,732,000 | +47.8% | 64,500 | +28.7% | 0.01% | +40.0% |
| Q1 2015 | $5,231,000 | +183.8% | 50,100 | +163.7% | 0.01% | +150.0% |
| Q4 2014 | $1,843,000 | +0.8% | 19,000 | -18.8% | 0.00% | 0.0% |
| Q3 2014 | $1,828,000 | +139.3% | 23,400 | +93.4% | 0.00% | +100.0% |
| Q2 2014 | $764,000 | -28.5% | 12,100 | -23.9% | 0.00% | 0.0% |
| Q1 2014 | $1,068,000 | +7.8% | 15,900 | +3.2% | 0.00% | 0.0% |
| Q4 2013 | $991,000 | -31.2% | 15,400 | -31.6% | 0.00% | -50.0% |
| Q3 2013 | $1,440,000 | +262.7% | 22,500 | +75.8% | 0.00% | +100.0% |
| Q2 2013 | $397,000 | – | 12,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 12,500 | $1,177,000 | 0.01% |
| Timber Hill LLC | 7,700 | $725,000 | 0.00% |
| SIMPLEX TRADING, LLC | 189 | $46,000 | 0.00% |
| Citadel Advisors | 10,500 | $988,000 | 0.00% |